GIP is a 42 amino acid peptide hormone that is released from K-cells of the small intestine, primarily in response to fat (and to a lesser extent glucose) ingestion, and potentiates glucose-stimulated insulin secretion [14] through a specific GIP receptor (GIPR) [15]
While exact dosing varies, the microdosing GLP-1 approach generally includes: Starting with a lower dose than standard treatment (such as Ozempic or Mounjaro) to allow the body to adjust Gradual adjustments over time based on tolerance, appetite changes, and results Monitoring appetite, digestion, and energy levels to guide dosing decisions Tracking weight and overall progress to ensure the approach is effective Because GLP-1 medications affect metabolism and blood sugar, this approach should always be individualized
Exosomes are tiny vesicles that enhance cellular communication, accelerating the regeneration process
You can try the platform with no commitment for 30 days
J Physiol 601(6):10611075 Stevenson-Hoare J, Schalkamp AK, Sandor C, Hardy J, Escott-Price V (2023) New cases of dementia are rising in elderly populations in Wales, UK
